StockWatch
·
Biotechnology: Pharmaceutical Preparations
InvestmentMay 8, 2026, 08:18 AM

InflaRx Completes $150M Underwritten Offering of 75M Shares

AI Summary

InflaRx N.V. announced the completion of its underwritten offering, raising aggregate gross proceeds of $150 million. The company sold 75,000,000 ordinary shares at an offering price of $2.00 per share. The net proceeds are intended to advance pipeline activities and for general corporate purposes, with participation from both new and existing investors.

Key Highlights

  • InflaRx completed an underwritten offering of 75,000,000 ordinary shares.
  • The offering price was $2.00 per ordinary share.
  • Aggregate gross proceeds totaled $150 million before deductions.
  • Net proceeds will fund pipeline activities, working capital, and general corporate purposes.
  • New and existing investors, including TCGX and Farallon Capital, participated.
  • Guggenheim Securities acted as lead bookrunner for the offering.